Drugs

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for the drug sparsentan, also known as Filspari, for the treatment of primary immunoglobulin A nephropathy (IgAN). Renowned as IgA nephropathy or Berger’s disease, this kidney disorder arises […]

Abbott, a leader in the healthcare sector, revealed significant new findings concerning its Amplatzer Amulet Left Atrial Appendage (LAA) Occluder for individuals with atrial fibrillation (AFib) who face heightened stroke risk. Recent five-year research highlights that patients using Abbott’s Amplatzer

Biosion, Inc. (Biosion), a global biotechnology company in the R&D phase, unveiled a new exclusive licensing deal with Aclaris Therapeutics. This agreement grants Biosion universal rights (excluding Greater China) for BSI-045B, a potential pioneering, clinical-stage, innovative anti-TSLP monoclonal antibody, in

AVPN, recognized as Asia’s leading social investment network, has introduced the ‘Climate x Health: Lighthouse for Asia’ initiative with support from the Bayer Foundation. The US$ 5 million fund was unveiled at the Singapore Pavilion during COP29 in Baku, Azerbaijan.

**Endo’s Expansion on Clonazepam Tablet Recall Over Potential Packaging Mislabeling** Endo, Inc., a multifaceted pharmaceutical corporation, has communicated that its subsidiary, Endo USA, Inc., will be broadening the initial voluntary recall of clonazepam orally disintegrating tablets, USP (C-IV). This decision

The Telangana government has reported remarkable strides in the life sciences sector, successfully securing over Rs. 36,000 crore in investments from more than 140 initiatives in the past year. These investments are poised to create 51,000 direct employment opportunities and

GSK plc has unveiled encouraging top-line results from the GLISTEN trial, an expansive Phase III clinical study investigating the efficacy of linerixibat, a novel targeted inhibitor of the ileal bile acid transporter (IBAT), in treating adults suffering from cholestatic pruritus

The Asia Pharma Expo 2025 & Asia Lab Expo 2025, a premier international pharmaceutical trade platform in the region, is set to be held at the BBCFEC, Purbachal, Dhaka from February 12-14, 2025. This event serves as a remarkable opportunity

Lupin Limited, an internationally recognized pharmaceutical company, has announced the release of its FDA-approved bumetanide injection USP in the United States. Available in two forms, the medication comes in 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL

The National Pharmaceutical Pricing Authority (NPPA) has updated the ceiling prices for six specific drug formulations in response to review orders favoring various companies made in October. These reforms impact the pricing of local anesthetics, such as lignocaine injections at